Cerus (CERS) Cash & Equivalents (2010 - 2026)
Cerus (CERS) posted Cash & Equivalents of $18.0 million for Q2 2026, down 35.44% sequentially from $27.8 million in Q1 2026, and up 12.44% YoY from $16.0 million in Q2 2025.
Cerus (CERS) Cash & Equivalents (2010 - 2026) Analysis & Trends
Cerus has reported Cash & Equivalents for 17 years, with the latest figure at $18.0 million in Q2 2026.
- Quarterly Cash & Equivalents rose 12.44% year-over-year to $18.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $18.0 million (up 12.44% YoY) and the FY2025 annual result came in at $20.0 million, down 1.5% from the prior year.
- Cash & Equivalents fell to $18.0 million in Q2 2026 per CERS's latest filing, from $27.8 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $38.4 million in Q1 2022 and troughed at $11.6 million in Q4 2023.
- A 5-year average of $22.5 million and a median of $20.4 million in 2024 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2023 and 2024: Cash & Equivalents tumbled 67.27% in 2023, then jumped 74.0% in 2024.
- Over 5 years, Cash & Equivalents stood at $35.6 million in 2022, then sank by 67.27% to $11.6 million in 2023, then surged by 74.0% to $20.3 million in 2024, then decreased by 1.5% to $20.0 million in 2025, then dropped by 9.92% to $18.0 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $18.0 million, $27.8 million, and $20.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Cerus | 560.58 Mn | 504.32 Mn | 29.53 Mn | 17.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.98 Mn |
| Mar 31, 2026 | 27.85 Mn |
| Dec 31, 2025 | 19.96 Mn |
| Sep 30, 2025 | 15.67 Mn |
| Jun 30, 2025 | 15.99 Mn |
| Mar 31, 2025 | 19.48 Mn |
| Dec 31, 2024 | 20.27 Mn |
| Sep 30, 2024 | 21.58 Mn |
| Jun 30, 2024 | 12.40 Mn |
| Mar 31, 2024 | 20.53 Mn |
| Dec 31, 2023 | 11.65 Mn |
| Sep 30, 2023 | 17.39 Mn |
| Jun 30, 2023 | 20.64 Mn |
| Mar 31, 2023 | 27.60 Mn |
| Dec 31, 2022 | 35.59 Mn |
| Sep 30, 2022 | 28.88 Mn |
| Jun 30, 2022 | 32.31 Mn |
| Mar 31, 2022 | 38.37 Mn |
| Dec 31, 2021 | 48.76 Mn |
| Sep 30, 2021 | 78.46 Mn |